Toll-like Receptor 9 Promotes Initiation of Gastric Tumorigenesis by Augmenting Inflammation and Cellular Proliferation

Gastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate immune pathogenic sensors that mediate chronic inflammatory and oncogenic responses. Here, we investigated the role of TLR9 in the pathogenesis of GC, includin...

Full description

Saved in:
Bibliographic Details
Published in:Cellular and Molecular Gastroenterology and Hepatology Vol. 14; no. 3; pp. 567 - 586
Main Authors: Tang, Ke, McLeod, Louise, Livis, Thaleia, West, Alison C., Dawson, Ruby, Yu, Liang, Balic, Jesse J., Chonwerawong, Michelle, Wray-McCann, Georgie, Oshima, Hiroko, Oshima, Masanobu, Deswaerte, Virginie, Ferrero, Richard L., Jenkins, Brendan J.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01.01.2022
Elsevier BV
Elsevier
Subjects:
ISSN:2352-345X, 2352-345X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Gastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate immune pathogenic sensors that mediate chronic inflammatory and oncogenic responses. Here, we investigated the role of TLR9 in the pathogenesis of GC, including Helicobacter infection. TLR9 gene expression was profiled in gastric tissues from GC and gastritis patients and from the spontaneous gp130F/F GC mouse model and chronic H felis-infected wild-type (WT) mice. Gastric pathology was compared in gp130F/F and H felis infection models with or without genetic ablation of Tlr9. The impact of Tlr9 targeting on signaling cascades implicated in inflammation and tumorigenesis (eg, nuclear factor kappa B, extracellular signal-related kinase, and mitogen-activated protein kinase) was assessed in vivo. A direct growth-potentiating effect of TLR9 ligand stimulation on human GC cell lines and gp130F/F primary gastric epithelial cells was also evaluated. TLR9 expression was up-regulated in Helicobacter-infected gastric tissues from GC and gastritis patients and gp130F/F and H felis-infected WT mice. Tlr9 ablation suppressed initiation of tumorigenesis in gp130F/F:Tlr9-/- mice by abrogating gastric inflammation and cellular proliferation. Tlr9-/- mice were also protected against H felis-induced gastric inflammation and hyperplasia. The suppressed gastric pathology upon Tlr9 ablation in both mouse models associated with attenuated nuclear factor kappa B and, to a lesser extent, extracellular signal-related kinase, mitogen-activated protein kinase signaling. TLR9 ligand stimulation of human GC cells and gp130F/F GECs augmented their proliferation and viability. Our data reveal that TLR9 promotes the initiating stages of GC and facilitates Helicobacter-induced gastric inflammation and hyperplasia, thus providing in vivo evidence for TLR9 as a candidate therapeutic target in GC.
AbstractList Gastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate immune pathogenic sensors that mediate chronic inflammatory and oncogenic responses. Here, we investigated the role of TLR9 in the pathogenesis of GC, including Helicobacter infection. TLR9 gene expression was profiled in gastric tissues from GC and gastritis patients and from the spontaneous gp130F/F GC mouse model and chronic H felis-infected wild-type (WT) mice. Gastric pathology was compared in gp130F/F and H felis infection models with or without genetic ablation of Tlr9. The impact of Tlr9 targeting on signaling cascades implicated in inflammation and tumorigenesis (eg, nuclear factor kappa B, extracellular signal-related kinase, and mitogen-activated protein kinase) was assessed in vivo. A direct growth-potentiating effect of TLR9 ligand stimulation on human GC cell lines and gp130F/F primary gastric epithelial cells was also evaluated. TLR9 expression was up-regulated in Helicobacter-infected gastric tissues from GC and gastritis patients and gp130F/F and H felis-infected WT mice. Tlr9 ablation suppressed initiation of tumorigenesis in gp130F/F:Tlr9-/- mice by abrogating gastric inflammation and cellular proliferation. Tlr9-/- mice were also protected against H felis-induced gastric inflammation and hyperplasia. The suppressed gastric pathology upon Tlr9 ablation in both mouse models associated with attenuated nuclear factor kappa B and, to a lesser extent, extracellular signal-related kinase, mitogen-activated protein kinase signaling. TLR9 ligand stimulation of human GC cells and gp130F/F GECs augmented their proliferation and viability. Our data reveal that TLR9 promotes the initiating stages of GC and facilitates Helicobacter-induced gastric inflammation and hyperplasia, thus providing in vivo evidence for TLR9 as a candidate therapeutic target in GC.
Background & AimsGastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate immune pathogenic sensors that mediate chronic inflammatory and oncogenic responses. Here, we investigated the role of TLR9 in the pathogenesis of GC, including Helicobacter infection. MethodsTLR9 gene expression was profiled in gastric tissues from GC and gastritis patients and from the spontaneous gp130F/F GC mouse model and chronic H felis-infected wild-type (WT) mice. Gastric pathology was compared in gp130F/F and H felis infection models with or without genetic ablation of Tlr9. The impact of Tlr9 targeting on signaling cascades implicated in inflammation and tumorigenesis (eg, nuclear factor kappa B, extracellular signal-related kinase, and mitogen-activated protein kinase) was assessed in vivo. A direct growth-potentiating effect of TLR9 ligand stimulation on human GC cell lines and gp130F/F primary gastric epithelial cells was also evaluated. ResultsTLR9 expression was up-regulated in Helicobacter-infected gastric tissues from GC and gastritis patients and gp130F/F and H felis-infected WT mice. Tlr9 ablation suppressed initiation of tumorigenesis in gp130F/F:Tlr9-/- mice by abrogating gastric inflammation and cellular proliferation. Tlr9-/- mice were also protected against H felis-induced gastric inflammation and hyperplasia. The suppressed gastric pathology upon Tlr9 ablation in both mouse models associated with attenuated nuclear factor kappa B and, to a lesser extent, extracellular signal-related kinase, mitogen-activated protein kinase signaling. TLR9 ligand stimulation of human GC cells and gp130F/F GECs augmented their proliferation and viability. ConclusionsOur data reveal that TLR9 promotes the initiating stages of GC and facilitates Helicobacter-induced gastric inflammation and hyperplasia, thus providing in vivo evidence for TLR9 as a candidate therapeutic target in GC.
Gastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate immune pathogenic sensors that mediate chronic inflammatory and oncogenic responses. Here, we investigated the role of TLR9 in the pathogenesis of GC, including Helicobacter infection.BACKGROUND & AIMSGastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate immune pathogenic sensors that mediate chronic inflammatory and oncogenic responses. Here, we investigated the role of TLR9 in the pathogenesis of GC, including Helicobacter infection.TLR9 gene expression was profiled in gastric tissues from GC and gastritis patients and from the spontaneous gp130F/F GC mouse model and chronic H felis-infected wild-type (WT) mice. Gastric pathology was compared in gp130F/F and H felis infection models with or without genetic ablation of Tlr9. The impact of Tlr9 targeting on signaling cascades implicated in inflammation and tumorigenesis (eg, nuclear factor kappa B, extracellular signal-related kinase, and mitogen-activated protein kinase) was assessed in vivo. A direct growth-potentiating effect of TLR9 ligand stimulation on human GC cell lines and gp130F/F primary gastric epithelial cells was also evaluated.METHODSTLR9 gene expression was profiled in gastric tissues from GC and gastritis patients and from the spontaneous gp130F/F GC mouse model and chronic H felis-infected wild-type (WT) mice. Gastric pathology was compared in gp130F/F and H felis infection models with or without genetic ablation of Tlr9. The impact of Tlr9 targeting on signaling cascades implicated in inflammation and tumorigenesis (eg, nuclear factor kappa B, extracellular signal-related kinase, and mitogen-activated protein kinase) was assessed in vivo. A direct growth-potentiating effect of TLR9 ligand stimulation on human GC cell lines and gp130F/F primary gastric epithelial cells was also evaluated.TLR9 expression was up-regulated in Helicobacter-infected gastric tissues from GC and gastritis patients and gp130F/F and H felis-infected WT mice. Tlr9 ablation suppressed initiation of tumorigenesis in gp130F/F:Tlr9-/- mice by abrogating gastric inflammation and cellular proliferation. Tlr9-/- mice were also protected against H felis-induced gastric inflammation and hyperplasia. The suppressed gastric pathology upon Tlr9 ablation in both mouse models associated with attenuated nuclear factor kappa B and, to a lesser extent, extracellular signal-related kinase, mitogen-activated protein kinase signaling. TLR9 ligand stimulation of human GC cells and gp130F/F GECs augmented their proliferation and viability.RESULTSTLR9 expression was up-regulated in Helicobacter-infected gastric tissues from GC and gastritis patients and gp130F/F and H felis-infected WT mice. Tlr9 ablation suppressed initiation of tumorigenesis in gp130F/F:Tlr9-/- mice by abrogating gastric inflammation and cellular proliferation. Tlr9-/- mice were also protected against H felis-induced gastric inflammation and hyperplasia. The suppressed gastric pathology upon Tlr9 ablation in both mouse models associated with attenuated nuclear factor kappa B and, to a lesser extent, extracellular signal-related kinase, mitogen-activated protein kinase signaling. TLR9 ligand stimulation of human GC cells and gp130F/F GECs augmented their proliferation and viability.Our data reveal that TLR9 promotes the initiating stages of GC and facilitates Helicobacter-induced gastric inflammation and hyperplasia, thus providing in vivo evidence for TLR9 as a candidate therapeutic target in GC.CONCLUSIONSOur data reveal that TLR9 promotes the initiating stages of GC and facilitates Helicobacter-induced gastric inflammation and hyperplasia, thus providing in vivo evidence for TLR9 as a candidate therapeutic target in GC.
Gastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate immune pathogenic sensors that mediate chronic inflammatory and oncogenic responses. Here, we investigated the role of TLR9 in the pathogenesis of GC, including Helicobacter infection. TLR9 gene expression was profiled in gastric tissues from GC and gastritis patients and from the spontaneous gp130 GC mouse model and chronic H felis-infected wild-type (WT) mice. Gastric pathology was compared in gp130 and H felis infection models with or without genetic ablation of Tlr9. The impact of Tlr9 targeting on signaling cascades implicated in inflammation and tumorigenesis (eg, nuclear factor kappa B, extracellular signal-related kinase, and mitogen-activated protein kinase) was assessed in vivo. A direct growth-potentiating effect of TLR9 ligand stimulation on human GC cell lines and gp130 primary gastric epithelial cells was also evaluated. TLR9 expression was up-regulated in Helicobacter-infected gastric tissues from GC and gastritis patients and gp130 and H felis-infected WT mice. Tlr9 ablation suppressed initiation of tumorigenesis in gp130 :Tlr9 mice by abrogating gastric inflammation and cellular proliferation. Tlr9 mice were also protected against H felis-induced gastric inflammation and hyperplasia. The suppressed gastric pathology upon Tlr9 ablation in both mouse models associated with attenuated nuclear factor kappa B and, to a lesser extent, extracellular signal-related kinase, mitogen-activated protein kinase signaling. TLR9 ligand stimulation of human GC cells and gp130 GECs augmented their proliferation and viability. Our data reveal that TLR9 promotes the initiating stages of GC and facilitates Helicobacter-induced gastric inflammation and hyperplasia, thus providing in vivo evidence for TLR9 as a candidate therapeutic target in GC.
Author Tang, Ke
Oshima, Masanobu
Oshima, Hiroko
Chonwerawong, Michelle
McLeod, Louise
Yu, Liang
Dawson, Ruby
Ferrero, Richard L.
Jenkins, Brendan J.
Wray-McCann, Georgie
West, Alison C.
Balic, Jesse J.
Deswaerte, Virginie
Livis, Thaleia
Author_xml – sequence: 1
  givenname: Ke
  surname: Tang
  fullname: Tang, Ke
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 2
  givenname: Louise
  surname: McLeod
  fullname: McLeod, Louise
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 3
  givenname: Thaleia
  surname: Livis
  fullname: Livis, Thaleia
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 4
  givenname: Alison C.
  surname: West
  fullname: West, Alison C.
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 5
  givenname: Ruby
  surname: Dawson
  fullname: Dawson, Ruby
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 6
  givenname: Liang
  surname: Yu
  fullname: Yu, Liang
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 7
  givenname: Jesse J.
  surname: Balic
  fullname: Balic, Jesse J.
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 8
  givenname: Michelle
  surname: Chonwerawong
  fullname: Chonwerawong, Michelle
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 9
  givenname: Georgie
  surname: Wray-McCann
  fullname: Wray-McCann, Georgie
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 10
  givenname: Hiroko
  surname: Oshima
  fullname: Oshima, Hiroko
  organization: Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
– sequence: 11
  givenname: Masanobu
  surname: Oshima
  fullname: Oshima, Masanobu
  organization: Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
– sequence: 12
  givenname: Virginie
  surname: Deswaerte
  fullname: Deswaerte, Virginie
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 13
  givenname: Richard L.
  surname: Ferrero
  fullname: Ferrero, Richard L.
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
– sequence: 14
  givenname: Brendan J.
  orcidid: 0000-0002-7552-4656
  surname: Jenkins
  fullname: Jenkins, Brendan J.
  email: Brendan.Jenkins@hudson.org.au
  organization: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
BackLink https://cir.nii.ac.jp/crid/1871146592895102848$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/35716851$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1rFDEYDlKxde0vEGQOHrzsmmQyyQSxUBZbCwVF9-AtZDPvbLPNJNtkprL_vpndVmpBe0kCeT6S53lfowMfPCD0luAZwYR_XM_WpltdzSimdIb5DGP6Ah3RsqLTklW_Dh6dD9FxSmuMMWGCC1y9QodlJQivK3KEfi-Cc1Nnr6H4AQY2fYiFLL7H0IUeUnHhbW91b4MvQluc69RHa4rF0IVoV-Ah2VQst8XpsOrA99avMqN1uuv2HO2bYg7ODU7HUdTZFuLu6g162WqX4Ph-n6DF2ZfF_Ov08tv5xfz0cmo4J_2UMMOXWBvOBEitRcPqkkrGQTAm9LJuW1obRgXHouZiaYhuiNGkbmRDtWzLCTrZy26GZQeNyY-M2qlNtJ2OWxW0VX_feHulVuFWyRILWfEs8OFeIIabAVKvOptM_pL2EIakKBc1KzEpZYa-e-z1x-Qh7AyQe4CJIaUIrTK236WRra1TBKuxW7VWu27V2K3CXOVuM7d8wn2Q_z_r_Z7lrc1m40pqQQjjlaS1rAimdU50gj7vYZCbuLUQVTIWvIHGRjC9aoJ9xubkCd-4bGa0u4YtpHUYos8lK6JS5qif42iOk0lpHkpMxmQ-_VvgWfs7tXj0Hw
CitedBy_id crossref_primary_10_1186_s12929_025_01151_9
crossref_primary_10_3389_fmed_2022_1057252
crossref_primary_10_1038_s41392_024_01765_9
crossref_primary_10_3389_fcell_2024_1513426
crossref_primary_10_1111_imcb_12641
crossref_primary_10_1016_j_intimp_2024_113253
crossref_primary_10_1007_s00432_023_05453_z
crossref_primary_10_1016_j_apsb_2025_09_007
crossref_primary_10_3389_fimmu_2023_1134785
crossref_primary_10_1128_spectrum_00015_24
crossref_primary_10_3389_fgene_2023_1280051
crossref_primary_10_3748_wjg_v29_i15_2222
crossref_primary_10_3390_cells13201708
Cites_doi 10.1155/2018/9050715
10.1002/eji.200636562
10.1007/978-981-10-5987-2_9
10.1186/1471-2407-10-415
10.1038/s41467-019-13479-6
10.1128/IAI.01226-09
10.1371/journal.pone.0101342
10.1016/j.ccr.2012.08.010
10.1371/journal.pgen.1000676
10.3748/wjg.v23.i9.1521
10.3748/wjg.v12.i3.354
10.2174/1381612821666150514104411
10.1007/978-1-62703-005-2_20
10.3892/or.2014.3095
10.1158/0008-5472.CAN-19-0974
10.1084/jem.20142162
10.1128/IAI.01481-07
10.1016/j.imbio.2016.06.009
10.1128/IAI.69.2.1025-1031.2001
10.1016/j.ajpath.2020.01.021
10.1038/onc.2017.121
10.1152/ajpgi.00175.2016
10.3390/toxins9040119
10.1016/j.humimm.2014.06.001
10.1038/nm1282
10.1371/journal.pone.0015018
10.1053/j.gastro.2015.02.049
10.1111/j.1574-695X.2007.00338.x
10.1053/j.gastro.2009.02.077
10.1002/ijc.28413
10.2353/ajpath.2010.100328
10.1172/JCI31414
10.1158/2326-6066.CIR-19-0623
10.1158/1541-7786.MCR-07-2005
10.1002/path.2933
10.1128/CMR.00011-10
10.1158/0008-5472.CAN-14-1151
10.1016/j.jcmgh.2019.05.008
10.1038/nri3446
10.1016/j.jss.2010.12.021
10.1053/j.gastro.2015.11.049
10.1053/j.gastro.2020.03.009
10.1038/35047123
10.1038/nmeth.2089
10.1158/0008-5472.CAN-17-1887
10.1038/s41568-022-00462-5
10.1016/0016-5085(90)91156-Z
10.1002/glia.20401
10.1053/j.gastro.2009.02.066
10.1007/s13277-013-1424-5
10.1016/j.bbrc.2012.08.080
ContentType Journal Article
Copyright 2022 The Authors
The Authors
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
2022 The Authors 2022
Copyright_xml – notice: 2022 The Authors
– notice: The Authors
– notice: Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
– notice: 2022 The Authors 2022
DBID 6I.
AAFTH
RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.jcmgh.2022.06.002
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2352-345X
EndPage 586
ExternalDocumentID PMC9307956
35716851
10_1016_j_jcmgh_2022_06_002
S2352345X22001011
1_s2_0_S2352345X22001011
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Health and Medical Research Council
  funderid: https://doi.org/10.13039/501100000925
– fundername: NHMRC
  funderid: https://doi.org/10.13039/501100000925
– fundername: Monash International Postgraduate Research Scholarships
– fundername: Victorian Government
  funderid: https://doi.org/10.13039/501100004752
GroupedDBID .1-
.FO
0R~
1P~
4.4
457
53G
AAEDT
AAEDW
AAIKJ
AALRI
AAXUO
AAYWO
ABMAC
ACGFS
ACVFH
ADBBV
ADCNI
ADEZE
ADRAZ
ADVLN
AEUPX
AEVXI
AEXQZ
AFJKZ
AFPUW
AFRHN
AFTJW
AGHFR
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BCNDV
EBS
EJD
FDB
GROUPED_DOAJ
HYE
KQ8
M41
M48
O9-
OC.
OK1
ON0
ROL
RPM
SSZ
Z5R
AACTN
0SF
6I.
AAFTH
NCXOZ
RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c661t-14c6b0ac647e9aa7d4832946e7447ab8ff28c427607867bc1ad1ca18d9d2a9f3
ISICitedReferencesCount 14
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000860358300004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2352-345X
IngestDate Thu Aug 21 18:17:21 EDT 2025
Fri Jul 11 14:00:05 EDT 2025
Sat Nov 01 14:17:01 EDT 2025
Wed Nov 12 18:32:22 EST 2025
Tue Nov 18 21:39:24 EST 2025
Thu Jun 26 22:51:14 EDT 2025
Fri Feb 23 02:39:06 EST 2024
Wed Apr 02 07:43:54 EDT 2025
Tue Aug 26 16:32:11 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords PCNA
MAPK
H pylori
TME
TCGA
NF-κB
PI3K
ANOVA
Gastric Cancer
TLR9
qPCR
TLR
GC
Initiation
WT
ERK
nuclear factor kappa B
mitogen-activated protein kinase
analysis of variance
extracellular signal-related kinase
quantitative polymerase chain reaction
The Cancer Genome Atlas
proliferating cell nuclear antigen
toll-like receptor
phosphatidylinositol-3′-kinase
tumor microenvironment
wild-type
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c661t-14c6b0ac647e9aa7d4832946e7447ab8ff28c427607867bc1ad1ca18d9d2a9f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7552-4656
0000-0001-9797-7800
0009-0005-3156-9392
0000-0003-3282-025x
OpenAccessLink http://dx.doi.org/10.1016/j.jcmgh.2022.06.002
PMID 35716851
PQID 2678430139
PQPubID 23479
PageCount 20
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307956
proquest_miscellaneous_2678430139
pubmed_primary_35716851
crossref_citationtrail_10_1016_j_jcmgh_2022_06_002
crossref_primary_10_1016_j_jcmgh_2022_06_002
nii_cinii_1871146592895102848
elsevier_sciencedirect_doi_10_1016_j_jcmgh_2022_06_002
elsevier_clinicalkeyesjournals_1_s2_0_S2352345X22001011
elsevier_clinicalkey_doi_10_1016_j_jcmgh_2022_06_002
PublicationCentury 2000
PublicationDate 2022-01-01
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cellular and Molecular Gastroenterology and Hepatology
PublicationTitleAlternate Cell Mol Gastroenterol Hepatol
PublicationYear 2022
Publisher Elsevier Inc
Elsevier BV
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier BV
– name: Elsevier
References Wroblewski, Peek, Wilson (bib3) 2010; 23
Eaton, Mefford (bib34) 2001; 69
Otani, Tanigawa, Watanabe, Nadatani, Sogawa, Yamagami, Shiba, Watanabe, Tominaga, Fujiwara, Arakawa (bib22) 2012; 426
Choi, Hendley, Bailey, Leach, Goldenring (bib31) 2016; 150
Chonwerawong, Ferrand, Chaudhry, Higgins, Tran, Lim, Walker, Bhathal, Dev, Moore, Sievert, Jenkins, Elios, Philpott, Kufer, Ferrero (bib52) 2020; 159
Hemmi, Takeuchi, Kawai, Kaisho, Sato, Sanjo, Matsumoto, Hoshino, Wagner, Takeda, Akira (bib51) 2000; 408
Ooi, Ivanova, Wu, Lee, Tan, Tao, Ward, Koo, Gopalakrishnan, Zhu, Cheng, Lee, Rha, Chung, Ganesan, So, Soo, Lim, Chan, Wong, Bowtell, Yeoh, Grabsch, Boussioutas, Tan (bib24) 2009; 5
Ishii, Shibata, Sugimori, Kaneta, Kanno, Sato, Sue, Kameta, Kaneko, Irie, Sasaki, Kondo, Maeda (bib41) 2018; 2018
Anderson, Worku, Khamri, Bamford, Walker, Thursz (bib23) 2007; 37
Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib1) 2018; 68
Li, Balic, Yu, Jenkins (bib35) 2017; 1024
Ferrero, Wilson, Sutton (bib53) 2012; 921
Wang, Cao, Yan, Ying, Jiang, Xu, Wu (bib17) 2010; 10
Balic, Saad, Dawson, West, McLeod, West, Costa, Deswaerte, Dev, Sievert, Gough, Bhathal, Ferrero, Jenkins (bib54) 2020; 190
Dai, Li, Chai, Long, Yang (bib16) 2014; 35
Tye, Kennedy, Najdovska, Mcleod, Mccormack, Hughes, Dev, Sievert, Ooi, Ishikawa, Oshima, Bhathal, Parker, Oshima, Tan, Jenkins (bib8) 2012; 22
Lehours, Ferrero (bib48) 2019; 24
Lee, Fox, Otto, Murphy (bib28) 1990; 99
Tsugawa, Kato, Mori, Matsuzaki, Kameyama, Saya, Hatakeyama, Suematsu, Suzuki (bib33) 2019; 8
Poh, Dwyer, Eissmann, Chand, Baloyan, Boon, Murrey, Whitehead, Brien, Lowell, Putoczki, Pixley, Donoghue, Ernst (bib27) 2020; 8
Dajon, Iribarren, Cremer (bib19) 2017; 222
Ying, Ferrero (bib43) 2019; 421
Zambirinis, Levie, Nguy, Avanzi, Barilla, Xu, Seifert, Daley, Greco, Deutsch, Jonnadula, Torres-Hernandez, Tippens, Pushalkar, Eisenthal, Saxena, Ahn, Hajdu, Engle, Tuveson, Miller (bib13) 2015; 212
Herrmann, Cherryholmes, Schroeder, Phallen, Alizadeh, Xin, Wang, Lee, Lahtz, Swiderski, Armstrong, Kowolik, Gallia, Lim, Brown, Badie, Forman, Kortylewski, Jove, Yu (bib38) 2014; 74
Deswaerte, Nguyen, West, Browning, Yu, Ruwanpura, Balic, Livis, Girard, Preaudet, Oshima, Fung, Tye, Najdovska, Ernst, Oshima, Gabay, Putoczki, Jenkins (bib58) 2018; 78
Sigal, Rothenberg, Logan, Lee, Honaker, Cooper, Passarelli, Camorlinga, Bouley, Alvarez, Nusse, Torres, Amieva (bib29) 2015; 148
Kaparakis, Walduck, Price, Pedersen, Van Rooijen, Pearse, Wijburg, Strugnell (bib46) 2008; 76
Quiding-Jarbrink, Raghavan, Sundquist (bib47) 2010; 5
Castaño-Rodríguez, Kaakoush, Pardo, Goh, Fock, Mitchell (bib10) 2014; 75
Dawson, Deswaerte, West, Tang, West, Balic, Gearing, Saad, Yu, Wu, Bhathal, Kumar, Chakrabarti, Zavros, Oshima, Klinman, Oshima, Tan, Jenkins (bib57) 2021
Lennerz, Kim, Oates, Huh, Doherty, Tian, Bredemeyer, Goldenring, Lauwers, Shin, Mills (bib30) 2010; 177
Min, Vega, Engevik, Williams, Yang, Patterson, Simmons, Bliton, Betts, Lau, Magness, Goldenring, Choi (bib32) 2019; 10
Schneider, Rasband, Eliceiri (bib56) 2012; 9
Neill, Golenbock, Bowie (bib6) 2013; 13
West, Jenkins (bib7) 2015; 21
Wang, Peng, Qiao, Zhu, Zhao, Shen, Ran (bib18) 2014; 7
Velin, Favre, Bernasconi, Bachmann, Pythoud, Saiji, Bouzourene, Michetti (bib55) 2009; 136
West, Tang, Tye, Yu, Deng, Najdovska, Lin, Balic, Okochi-Takada, McGuirk, Keogh, McCormack, Bhathal, Reilly, Oshima, Ushijima, Tan, Jenkins (bib11) 2017; 36
Zhang, Wang, Ma, Li, Li, Wang (bib15) 2014; 31
Sokolova, Naumann (bib42) 2017; 9
Crew, Neugut (bib2) 2006; 12
Jenkins, Grail, Nheu, Najdovska, Wang, Waring, Inglese, McLoughlin, Jones, Topley, Baumann, Judd, Giraud, Boussioutas, Zhu, Ernst (bib26) 2005; 11
Ng, Va’t Hof, Crockett, Hope, Berry, Thomson, McLean, McColl, El-Omar, Hold (bib44) 2010; 78
Castaño-Rodriguez, Kaakoush, Mitchell (bib4) 2014; 5
Ilvesaro, Merrell, Li, Wakchoure, Graves, Brooks, Rahko, Jukkola-Vuorinen, Vuopala, Harris, Selander (bib14) 2008; 6
Varga, Piazuelo, Romero-Gallo, Delgado, Suarez, Whitaker, Krishna, Patel, Skaar, Wilson, Algood, Peek (bib21) 2016; 311
El Andaloussi, Sonabend, Han, Lesniak (bib37) 2006; 54
Kim, Yan, Tohme, Ahmed, Cordon-Cardo, Shantha Kumara, Kim, Whelan (bib36) 2012; 174
Chmiela, Karwowska, Gonciarz, Allushi, Staczek (bib5) 2017; 23
Man, Jenkins (bib9) 2022
Kennedy, Najdovska, Jones, McLeod, Hughes, Allison, Ooi, Tan, Ferrero, Jones, Dev, Sievert, Bhathal, Jenkins (bib49) 2011; 225
Krieg (bib20) 2007; 117
Belmont, Rabbe, Antoine, Cathelin, Guignabert, Kurie, Cadranel, Wislez (bib12) 2014; 134
Alvarez-Arellano, Cortés-Reynosa, Sánchez-Zauco, Salazar, Torres, Maldonado-Bernal (bib40) 2014; 9
Algood, Gallo-Romero, Wilson, Peek, Cover (bib45) 2007; 51
Balic, Garama, Saad, Yu, West, West, Livis, Bhathal, Gough, Jenkins (bib25) 2019; 79
Rad, Ballhorn, Voland, Eisenacher, Mages, Rad, Ferstl, Lang, Wagner, Schmid, Bauer, Prinz, Kirschning, Krug (bib39) 2009; 136
Ernst, Najdovska, Grail, Lundgren-May, Buchert, Tye, Matthews, Armes, Bhathal, Hughes, Marcusson, Karras, Na, Sedgwick, Hertzog, Jenkins (bib50) 2008; 118
Wang (10.1016/j.jcmgh.2022.06.002_bib17) 2010; 10
Jenkins (10.1016/j.jcmgh.2022.06.002_bib26) 2005; 11
Otani (10.1016/j.jcmgh.2022.06.002_bib22) 2012; 426
Dai (10.1016/j.jcmgh.2022.06.002_bib16) 2014; 35
Dajon (10.1016/j.jcmgh.2022.06.002_bib19) 2017; 222
Lee (10.1016/j.jcmgh.2022.06.002_bib28) 1990; 99
Zhang (10.1016/j.jcmgh.2022.06.002_bib15) 2014; 31
Rad (10.1016/j.jcmgh.2022.06.002_bib39) 2009; 136
Hemmi (10.1016/j.jcmgh.2022.06.002_bib51) 2000; 408
Ferrero (10.1016/j.jcmgh.2022.06.002_bib53) 2012; 921
Bray (10.1016/j.jcmgh.2022.06.002_bib1) 2018; 68
Wroblewski (10.1016/j.jcmgh.2022.06.002_bib3) 2010; 23
Balic (10.1016/j.jcmgh.2022.06.002_bib25) 2019; 79
Ng (10.1016/j.jcmgh.2022.06.002_bib44) 2010; 78
West (10.1016/j.jcmgh.2022.06.002_bib11) 2017; 36
Eaton (10.1016/j.jcmgh.2022.06.002_bib34) 2001; 69
Min (10.1016/j.jcmgh.2022.06.002_bib32) 2019; 10
Chonwerawong (10.1016/j.jcmgh.2022.06.002_bib52) 2020; 159
Castaño-Rodriguez (10.1016/j.jcmgh.2022.06.002_bib4) 2014; 5
Kaparakis (10.1016/j.jcmgh.2022.06.002_bib46) 2008; 76
Belmont (10.1016/j.jcmgh.2022.06.002_bib12) 2014; 134
Ooi (10.1016/j.jcmgh.2022.06.002_bib24) 2009; 5
Schneider (10.1016/j.jcmgh.2022.06.002_bib56) 2012; 9
Neill (10.1016/j.jcmgh.2022.06.002_bib6) 2013; 13
Anderson (10.1016/j.jcmgh.2022.06.002_bib23) 2007; 37
Poh (10.1016/j.jcmgh.2022.06.002_bib27) 2020; 8
Ilvesaro (10.1016/j.jcmgh.2022.06.002_bib14) 2008; 6
Dawson (10.1016/j.jcmgh.2022.06.002_bib57) 2021
Alvarez-Arellano (10.1016/j.jcmgh.2022.06.002_bib40) 2014; 9
Lennerz (10.1016/j.jcmgh.2022.06.002_bib30) 2010; 177
Crew (10.1016/j.jcmgh.2022.06.002_bib2) 2006; 12
Kennedy (10.1016/j.jcmgh.2022.06.002_bib49) 2011; 225
Ishii (10.1016/j.jcmgh.2022.06.002_bib41) 2018; 2018
Deswaerte (10.1016/j.jcmgh.2022.06.002_bib58) 2018; 78
Ying (10.1016/j.jcmgh.2022.06.002_bib43) 2019; 421
Quiding-Jarbrink (10.1016/j.jcmgh.2022.06.002_bib47) 2010; 5
West (10.1016/j.jcmgh.2022.06.002_bib7) 2015; 21
Wang (10.1016/j.jcmgh.2022.06.002_bib18) 2014; 7
Krieg (10.1016/j.jcmgh.2022.06.002_bib20) 2007; 117
Herrmann (10.1016/j.jcmgh.2022.06.002_bib38) 2014; 74
Choi (10.1016/j.jcmgh.2022.06.002_bib31) 2016; 150
El Andaloussi (10.1016/j.jcmgh.2022.06.002_bib37) 2006; 54
Tye (10.1016/j.jcmgh.2022.06.002_bib8) 2012; 22
Kim (10.1016/j.jcmgh.2022.06.002_bib36) 2012; 174
Sokolova (10.1016/j.jcmgh.2022.06.002_bib42) 2017; 9
Lehours (10.1016/j.jcmgh.2022.06.002_bib48) 2019; 24
Sigal (10.1016/j.jcmgh.2022.06.002_bib29) 2015; 148
Velin (10.1016/j.jcmgh.2022.06.002_bib55) 2009; 136
Castaño-Rodríguez (10.1016/j.jcmgh.2022.06.002_bib10) 2014; 75
Ernst (10.1016/j.jcmgh.2022.06.002_bib50) 2008; 118
Zambirinis (10.1016/j.jcmgh.2022.06.002_bib13) 2015; 212
Li (10.1016/j.jcmgh.2022.06.002_bib35) 2017; 1024
Tsugawa (10.1016/j.jcmgh.2022.06.002_bib33) 2019; 8
Balic (10.1016/j.jcmgh.2022.06.002_bib54) 2020; 190
Varga (10.1016/j.jcmgh.2022.06.002_bib21) 2016; 311
Algood (10.1016/j.jcmgh.2022.06.002_bib45) 2007; 51
Chmiela (10.1016/j.jcmgh.2022.06.002_bib5) 2017; 23
Man (10.1016/j.jcmgh.2022.06.002_bib9) 2022
References_xml – volume: 78
  start-page: 1293
  year: 2018
  end-page: 1307
  ident: bib58
  article-title: Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism
  publication-title: Cancer Res
– volume: 75
  start-page: 808
  year: 2014
  end-page: 815
  ident: bib10
  article-title: Genetic polymorphisms in the toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer
  publication-title: Hum Immunol
– volume: 8
  start-page: 428
  year: 2020
  end-page: 435
  ident: bib27
  article-title: Inhibition of the SRC kinase HCK impairs STAT3-dependent gastric tumor growth in mice
  publication-title: Cancer Immunol Res
– volume: 136
  start-page: 2237
  year: 2009
  end-page: 2246
  ident: bib55
  article-title: Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model
  publication-title: Gastroenterology
– year: 2021
  ident: bib57
  article-title: STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis
  publication-title: Gut
– volume: 74
  start-page: 5218
  year: 2014
  end-page: 5228
  ident: bib38
  article-title: TLR9 is critical for glioma stem cell maintenance and targeting
  publication-title: Cancer Res
– volume: 24
  year: 2019
  ident: bib48
  article-title: Review: Helicobacter—inflammation, immunology, and vaccines
  publication-title: Helicobacter
– volume: 117
  start-page: 1184
  year: 2007
  end-page: 1194
  ident: bib20
  article-title: Development of TLR9 agonists for cancer therapy
  publication-title: J Clin Invest
– volume: 174
  start-page: 284
  year: 2012
  end-page: 290
  ident: bib36
  article-title: CpG ODN, toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model
  publication-title: J Surg Res
– volume: 51
  start-page: 577
  year: 2007
  end-page: 586
  ident: bib45
  article-title: Host response to Helicobacter pylori infection before initiation of the adaptive immune response
  publication-title: FEMS Immunol Med Microbiol
– volume: 408
  start-page: 740
  year: 2000
  end-page: 745
  ident: bib51
  article-title: A toll-like receptor recognizes bacterial DNA
  publication-title: Nature
– volume: 11
  start-page: 845
  year: 2005
  end-page: 852
  ident: bib26
  article-title: Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling
  publication-title: Nat Med
– volume: 5
  year: 2010
  ident: bib47
  article-title: Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice
  publication-title: pLoS One
– volume: 23
  start-page: 713
  year: 2010
  end-page: 739
  ident: bib3
  article-title: Helicobacter pylori and gastric cancer: factors that modulate disease risk
  publication-title: Clin Microbiol Rev
– volume: 99
  start-page: 1315
  year: 1990
  end-page: 1323
  ident: bib28
  article-title: A small animal model of human Helicobacter pylori active chronic gastritis
  publication-title: Gastroenterology
– volume: 177
  start-page: 1514
  year: 2010
  end-page: 1533
  ident: bib30
  article-title: The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma
  publication-title: Am J Pathol
– volume: 225
  start-page: 255
  year: 2011
  end-page: 264
  ident: bib49
  article-title: The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17
  publication-title: J Pathol
– volume: 79
  start-page: 5272
  year: 2019
  end-page: 5287
  ident: bib25
  article-title: Serine-phosphorylated STAT3 promotes tumorigenesis via modulation of RNA polymerase transcriptional activity
  publication-title: Cancer Res
– volume: 6
  start-page: 1534
  year: 2008
  end-page: 1543
  ident: bib14
  article-title: Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion
  publication-title: Mol Cancer Res
– volume: 22
  start-page: 466
  year: 2012
  end-page: 478
  ident: bib8
  article-title: STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation
  publication-title: Cancer Cell
– volume: 311
  start-page: G852
  year: 2016
  end-page: G858
  ident: bib21
  article-title: TLR9 activation suppresses inflammation in response to Helicobacter pylori infection
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 9
  year: 2014
  ident: bib40
  article-title: TLR9 and NF-κB are partially involved in activation of human neutrophils by Helicobacter pylori and its purified DNA
  publication-title: pLoS One
– volume: 921
  start-page: 157
  year: 2012
  end-page: 173
  ident: bib53
  article-title: Mouse models of Helicobacter-induced gastric cancer: use of cocarcinogens
  publication-title: Methods Mol Biol
– volume: 421
  start-page: 159
  year: 2019
  end-page: 177
  ident: bib43
  article-title: Role of NOD1 and ALPK1/TIFA signalling in innate immunity against Helicobacter pylori infection
  publication-title: Curr Top Microbiol Immunol
– volume: 190
  start-page: 1256
  year: 2020
  end-page: 1270
  ident: bib54
  article-title: Constitutive STAT3 serine phosphorylation promotes Helicobacter-mediated gastric disease
  publication-title: Am J Pathol
– volume: 10
  start-page: 5549
  year: 2019
  ident: bib32
  article-title: Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach
  publication-title: Nat Commun
– volume: 159
  start-page: 169
  year: 2020
  end-page: 182 e8
  ident: bib52
  article-title: Innate immune molecule NLRC5 protects mice from Helicobacter-induced formation of gastric lymphoid tissue
  publication-title: Gastroenterology
– volume: 426
  start-page: 342
  year: 2012
  end-page: 349
  ident: bib22
  article-title: Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pylori-induced gastritis
  publication-title: Biochem Biophys Res Commun
– volume: 37
  start-page: 1548
  year: 2007
  end-page: 1561
  ident: bib23
  article-title: TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan
  publication-title: Eur J Immunol
– volume: 1024
  start-page: 195
  year: 2017
  end-page: 212
  ident: bib35
  article-title: TLR agonists as adjuvants for cancer vaccines
  publication-title: Adv Exp Med Biol
– volume: 9
  start-page: 671
  year: 2012
  end-page: 675
  ident: bib56
  article-title: NIH Image to ImageJ: 25 years of image analysis
  publication-title: Nat Methods
– volume: 5
  start-page: 336
  year: 2014
  ident: bib4
  article-title: Pattern-recognition receptors and gastric cancer
  publication-title: Front Immunol
– volume: 21
  start-page: 2968
  year: 2015
  end-page: 2977
  ident: bib7
  article-title: Inflammatory and non-inflammatory roles for toll-like receptors in gastrointestinal cancer
  publication-title: Curr Pharm Des
– volume: 8
  start-page: 319
  year: 2019
  end-page: 334
  ident: bib33
  article-title: Cancer stem-cell marker CD44v9-positive cells arise from Helicobacter pylori-infected CAPZA1-overexpressing cells
  publication-title: Cell Mol Gastroenterol Hepatol
– volume: 23
  start-page: 1521
  year: 2017
  end-page: 1540
  ident: bib5
  article-title: Host pathogen interactions in Helicobacter pylori related gastric cancer
  publication-title: World J Gastroenterol
– volume: 134
  start-page: 765
  year: 2014
  end-page: 777
  ident: bib12
  article-title: Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer
  publication-title: Int J Cancer
– volume: 148
  start-page: 1392
  year: 2015
  end-page: 1404 e21
  ident: bib29
  article-title: Helicobacter pylori activates and expands Lgr5(+) stem cells through direct colonization of the gastric glands
  publication-title: Gastroenterology
– volume: 5
  year: 2009
  ident: bib24
  article-title: Oncogenic pathway combinations predict clinical prognosis in gastric cancer
  publication-title: pLoS Genet
– volume: 12
  start-page: 354
  year: 2006
  ident: bib2
  article-title: Epidemiology of gastric cancer
  publication-title: World J Gastroenterol
– volume: 31
  start-page: 2298
  year: 2014
  end-page: 2304
  ident: bib15
  article-title: Functional expression of TLR9 in esophageal cancer
  publication-title: Oncol Rep
– volume: 35
  start-page: 3247
  year: 2014
  end-page: 3253
  ident: bib16
  article-title: Polymorphisms of toll-like receptor 9 are associated with nasopharyngeal carcinoma susceptibility
  publication-title: Tumour Biol
– year: 2022
  ident: bib9
  article-title: Context-dependent functions of pattern recognition receptors in cancer
  publication-title: Nat Rev Cancer
– volume: 78
  start-page: 1345
  year: 2010
  end-page: 1352
  ident: bib44
  article-title: Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease
  publication-title: Infect Immun
– volume: 150
  start-page: 918
  year: 2016
  end-page: 930 e13
  ident: bib31
  article-title: Expression of activated Ras in gastric chief cells of mice leads to the full spectrum of metaplastic lineage transitions
  publication-title: Gastroenterology
– volume: 69
  start-page: 1025
  year: 2001
  end-page: 1031
  ident: bib34
  article-title: Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice
  publication-title: Infect Immun
– volume: 7
  start-page: 6950
  year: 2014
  end-page: 6955
  ident: bib18
  article-title: Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis
  publication-title: Int J Clin Exp Pathol
– volume: 13
  start-page: 453
  year: 2013
  end-page: 460
  ident: bib6
  article-title: The history of toll-like receptors: redefining innate immunity
  publication-title: Nat Rev Immunol
– volume: 212
  start-page: 2077
  year: 2015
  end-page: 2094
  ident: bib13
  article-title: TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
  publication-title: J Exp Med
– volume: 2018
  year: 2018
  ident: bib41
  article-title: Activation of signal transduction and activator of transcription 3 signaling contributes to Helicobacter-associated gastric epithelial proliferation and inflammation
  publication-title: Gastroenterol Res Pract
– volume: 222
  start-page: 89
  year: 2017
  end-page: 100
  ident: bib19
  article-title: Toll-like receptor stimulation in cancer: a pro- and anti-tumor double-edged sword
  publication-title: Immunobiology
– volume: 54
  start-page: 526
  year: 2006
  end-page: 535
  ident: bib37
  article-title: Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors
  publication-title: Glia
– volume: 36
  start-page: 5134
  year: 2017
  end-page: 5144
  ident: bib11
  article-title: Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer
  publication-title: Oncogene
– volume: 10
  start-page: 415
  year: 2010
  ident: bib17
  article-title: TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients
  publication-title: BMC Cancer
– volume: 136
  start-page: 2247
  year: 2009
  end-page: 2257
  ident: bib39
  article-title: Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori
  publication-title: Gastroenterology
– volume: 9
  start-page: 119
  year: 2017
  ident: bib42
  article-title: NF-κB signaling in gastric cancer
  publication-title: Toxins (Basel)
– volume: 68
  start-page: 394
  year: 2018
  end-page: 424
  ident: bib1
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 76
  start-page: 2235
  year: 2008
  end-page: 2239
  ident: bib46
  article-title: Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice
  publication-title: Infect Immun
– volume: 118
  start-page: 1727
  year: 2008
  end-page: 1738
  ident: bib50
  article-title: STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
  publication-title: J Clin Invest
– volume: 2018
  year: 2018
  ident: 10.1016/j.jcmgh.2022.06.002_bib41
  article-title: Activation of signal transduction and activator of transcription 3 signaling contributes to Helicobacter-associated gastric epithelial proliferation and inflammation
  publication-title: Gastroenterol Res Pract
  doi: 10.1155/2018/9050715
– volume: 37
  start-page: 1548
  year: 2007
  ident: 10.1016/j.jcmgh.2022.06.002_bib23
  article-title: TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200636562
– volume: 1024
  start-page: 195
  year: 2017
  ident: 10.1016/j.jcmgh.2022.06.002_bib35
  article-title: TLR agonists as adjuvants for cancer vaccines
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-981-10-5987-2_9
– volume: 10
  start-page: 415
  year: 2010
  ident: 10.1016/j.jcmgh.2022.06.002_bib17
  article-title: TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-10-415
– volume: 10
  start-page: 5549
  year: 2019
  ident: 10.1016/j.jcmgh.2022.06.002_bib32
  article-title: Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-13479-6
– volume: 78
  start-page: 1345
  year: 2010
  ident: 10.1016/j.jcmgh.2022.06.002_bib44
  article-title: Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease
  publication-title: Infect Immun
  doi: 10.1128/IAI.01226-09
– volume: 9
  year: 2014
  ident: 10.1016/j.jcmgh.2022.06.002_bib40
  article-title: TLR9 and NF-κB are partially involved in activation of human neutrophils by Helicobacter pylori and its purified DNA
  publication-title: pLoS One
  doi: 10.1371/journal.pone.0101342
– volume: 421
  start-page: 159
  year: 2019
  ident: 10.1016/j.jcmgh.2022.06.002_bib43
  article-title: Role of NOD1 and ALPK1/TIFA signalling in innate immunity against Helicobacter pylori infection
  publication-title: Curr Top Microbiol Immunol
– volume: 22
  start-page: 466
  year: 2012
  ident: 10.1016/j.jcmgh.2022.06.002_bib8
  article-title: STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.08.010
– volume: 118
  start-page: 1727
  year: 2008
  ident: 10.1016/j.jcmgh.2022.06.002_bib50
  article-title: STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
  publication-title: J Clin Invest
– volume: 5
  year: 2009
  ident: 10.1016/j.jcmgh.2022.06.002_bib24
  article-title: Oncogenic pathway combinations predict clinical prognosis in gastric cancer
  publication-title: pLoS Genet
  doi: 10.1371/journal.pgen.1000676
– volume: 23
  start-page: 1521
  year: 2017
  ident: 10.1016/j.jcmgh.2022.06.002_bib5
  article-title: Host pathogen interactions in Helicobacter pylori related gastric cancer
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v23.i9.1521
– volume: 12
  start-page: 354
  year: 2006
  ident: 10.1016/j.jcmgh.2022.06.002_bib2
  article-title: Epidemiology of gastric cancer
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v12.i3.354
– year: 2021
  ident: 10.1016/j.jcmgh.2022.06.002_bib57
  article-title: STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis
  publication-title: Gut
– volume: 21
  start-page: 2968
  year: 2015
  ident: 10.1016/j.jcmgh.2022.06.002_bib7
  article-title: Inflammatory and non-inflammatory roles for toll-like receptors in gastrointestinal cancer
  publication-title: Curr Pharm Des
  doi: 10.2174/1381612821666150514104411
– volume: 921
  start-page: 157
  year: 2012
  ident: 10.1016/j.jcmgh.2022.06.002_bib53
  article-title: Mouse models of Helicobacter-induced gastric cancer: use of cocarcinogens
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-62703-005-2_20
– volume: 31
  start-page: 2298
  year: 2014
  ident: 10.1016/j.jcmgh.2022.06.002_bib15
  article-title: Functional expression of TLR9 in esophageal cancer
  publication-title: Oncol Rep
  doi: 10.3892/or.2014.3095
– volume: 79
  start-page: 5272
  year: 2019
  ident: 10.1016/j.jcmgh.2022.06.002_bib25
  article-title: Serine-phosphorylated STAT3 promotes tumorigenesis via modulation of RNA polymerase transcriptional activity
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-0974
– volume: 212
  start-page: 2077
  year: 2015
  ident: 10.1016/j.jcmgh.2022.06.002_bib13
  article-title: TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
  publication-title: J Exp Med
  doi: 10.1084/jem.20142162
– volume: 76
  start-page: 2235
  year: 2008
  ident: 10.1016/j.jcmgh.2022.06.002_bib46
  article-title: Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice
  publication-title: Infect Immun
  doi: 10.1128/IAI.01481-07
– volume: 222
  start-page: 89
  year: 2017
  ident: 10.1016/j.jcmgh.2022.06.002_bib19
  article-title: Toll-like receptor stimulation in cancer: a pro- and anti-tumor double-edged sword
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2016.06.009
– volume: 69
  start-page: 1025
  year: 2001
  ident: 10.1016/j.jcmgh.2022.06.002_bib34
  article-title: Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice
  publication-title: Infect Immun
  doi: 10.1128/IAI.69.2.1025-1031.2001
– volume: 190
  start-page: 1256
  year: 2020
  ident: 10.1016/j.jcmgh.2022.06.002_bib54
  article-title: Constitutive STAT3 serine phosphorylation promotes Helicobacter-mediated gastric disease
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2020.01.021
– volume: 36
  start-page: 5134
  year: 2017
  ident: 10.1016/j.jcmgh.2022.06.002_bib11
  article-title: Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2017.121
– volume: 311
  start-page: G852
  year: 2016
  ident: 10.1016/j.jcmgh.2022.06.002_bib21
  article-title: TLR9 activation suppresses inflammation in response to Helicobacter pylori infection
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00175.2016
– volume: 5
  start-page: 336
  year: 2014
  ident: 10.1016/j.jcmgh.2022.06.002_bib4
  article-title: Pattern-recognition receptors and gastric cancer
  publication-title: Front Immunol
– volume: 9
  start-page: 119
  year: 2017
  ident: 10.1016/j.jcmgh.2022.06.002_bib42
  article-title: NF-κB signaling in gastric cancer
  publication-title: Toxins (Basel)
  doi: 10.3390/toxins9040119
– volume: 75
  start-page: 808
  year: 2014
  ident: 10.1016/j.jcmgh.2022.06.002_bib10
  article-title: Genetic polymorphisms in the toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2014.06.001
– volume: 11
  start-page: 845
  year: 2005
  ident: 10.1016/j.jcmgh.2022.06.002_bib26
  article-title: Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling
  publication-title: Nat Med
  doi: 10.1038/nm1282
– volume: 5
  year: 2010
  ident: 10.1016/j.jcmgh.2022.06.002_bib47
  article-title: Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice
  publication-title: pLoS One
  doi: 10.1371/journal.pone.0015018
– volume: 148
  start-page: 1392
  year: 2015
  ident: 10.1016/j.jcmgh.2022.06.002_bib29
  article-title: Helicobacter pylori activates and expands Lgr5(+) stem cells through direct colonization of the gastric glands
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.02.049
– volume: 51
  start-page: 577
  year: 2007
  ident: 10.1016/j.jcmgh.2022.06.002_bib45
  article-title: Host response to Helicobacter pylori infection before initiation of the adaptive immune response
  publication-title: FEMS Immunol Med Microbiol
  doi: 10.1111/j.1574-695X.2007.00338.x
– volume: 136
  start-page: 2237
  year: 2009
  ident: 10.1016/j.jcmgh.2022.06.002_bib55
  article-title: Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2009.02.077
– volume: 134
  start-page: 765
  year: 2014
  ident: 10.1016/j.jcmgh.2022.06.002_bib12
  article-title: Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer
  publication-title: Int J Cancer
  doi: 10.1002/ijc.28413
– volume: 177
  start-page: 1514
  year: 2010
  ident: 10.1016/j.jcmgh.2022.06.002_bib30
  article-title: The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2010.100328
– volume: 117
  start-page: 1184
  year: 2007
  ident: 10.1016/j.jcmgh.2022.06.002_bib20
  article-title: Development of TLR9 agonists for cancer therapy
  publication-title: J Clin Invest
  doi: 10.1172/JCI31414
– volume: 8
  start-page: 428
  year: 2020
  ident: 10.1016/j.jcmgh.2022.06.002_bib27
  article-title: Inhibition of the SRC kinase HCK impairs STAT3-dependent gastric tumor growth in mice
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-19-0623
– volume: 6
  start-page: 1534
  year: 2008
  ident: 10.1016/j.jcmgh.2022.06.002_bib14
  article-title: Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-07-2005
– volume: 225
  start-page: 255
  year: 2011
  ident: 10.1016/j.jcmgh.2022.06.002_bib49
  article-title: The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17
  publication-title: J Pathol
  doi: 10.1002/path.2933
– volume: 23
  start-page: 713
  year: 2010
  ident: 10.1016/j.jcmgh.2022.06.002_bib3
  article-title: Helicobacter pylori and gastric cancer: factors that modulate disease risk
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00011-10
– volume: 74
  start-page: 5218
  year: 2014
  ident: 10.1016/j.jcmgh.2022.06.002_bib38
  article-title: TLR9 is critical for glioma stem cell maintenance and targeting
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-1151
– volume: 8
  start-page: 319
  year: 2019
  ident: 10.1016/j.jcmgh.2022.06.002_bib33
  article-title: Cancer stem-cell marker CD44v9-positive cells arise from Helicobacter pylori-infected CAPZA1-overexpressing cells
  publication-title: Cell Mol Gastroenterol Hepatol
  doi: 10.1016/j.jcmgh.2019.05.008
– volume: 13
  start-page: 453
  year: 2013
  ident: 10.1016/j.jcmgh.2022.06.002_bib6
  article-title: The history of toll-like receptors: redefining innate immunity
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3446
– volume: 174
  start-page: 284
  year: 2012
  ident: 10.1016/j.jcmgh.2022.06.002_bib36
  article-title: CpG ODN, toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2010.12.021
– volume: 150
  start-page: 918
  year: 2016
  ident: 10.1016/j.jcmgh.2022.06.002_bib31
  article-title: Expression of activated Ras in gastric chief cells of mice leads to the full spectrum of metaplastic lineage transitions
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.11.049
– volume: 7
  start-page: 6950
  year: 2014
  ident: 10.1016/j.jcmgh.2022.06.002_bib18
  article-title: Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis
  publication-title: Int J Clin Exp Pathol
– volume: 24
  issue: Suppl 1
  year: 2019
  ident: 10.1016/j.jcmgh.2022.06.002_bib48
  article-title: Review: Helicobacter—inflammation, immunology, and vaccines
  publication-title: Helicobacter
– volume: 159
  start-page: 169
  year: 2020
  ident: 10.1016/j.jcmgh.2022.06.002_bib52
  article-title: Innate immune molecule NLRC5 protects mice from Helicobacter-induced formation of gastric lymphoid tissue
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.03.009
– volume: 408
  start-page: 740
  year: 2000
  ident: 10.1016/j.jcmgh.2022.06.002_bib51
  article-title: A toll-like receptor recognizes bacterial DNA
  publication-title: Nature
  doi: 10.1038/35047123
– volume: 9
  start-page: 671
  year: 2012
  ident: 10.1016/j.jcmgh.2022.06.002_bib56
  article-title: NIH Image to ImageJ: 25 years of image analysis
  publication-title: Nat Methods
  doi: 10.1038/nmeth.2089
– volume: 78
  start-page: 1293
  year: 2018
  ident: 10.1016/j.jcmgh.2022.06.002_bib58
  article-title: Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-1887
– year: 2022
  ident: 10.1016/j.jcmgh.2022.06.002_bib9
  article-title: Context-dependent functions of pattern recognition receptors in cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-022-00462-5
– volume: 99
  start-page: 1315
  year: 1990
  ident: 10.1016/j.jcmgh.2022.06.002_bib28
  article-title: A small animal model of human Helicobacter pylori active chronic gastritis
  publication-title: Gastroenterology
  doi: 10.1016/0016-5085(90)91156-Z
– volume: 54
  start-page: 526
  year: 2006
  ident: 10.1016/j.jcmgh.2022.06.002_bib37
  article-title: Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors
  publication-title: Glia
  doi: 10.1002/glia.20401
– volume: 136
  start-page: 2247
  year: 2009
  ident: 10.1016/j.jcmgh.2022.06.002_bib39
  article-title: Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2009.02.066
– volume: 35
  start-page: 3247
  year: 2014
  ident: 10.1016/j.jcmgh.2022.06.002_bib16
  article-title: Polymorphisms of toll-like receptor 9 are associated with nasopharyngeal carcinoma susceptibility
  publication-title: Tumour Biol
  doi: 10.1007/s13277-013-1424-5
– volume: 68
  start-page: 394
  year: 2018
  ident: 10.1016/j.jcmgh.2022.06.002_bib1
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 426
  start-page: 342
  year: 2012
  ident: 10.1016/j.jcmgh.2022.06.002_bib22
  article-title: Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pylori-induced gastritis
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2012.08.080
SSID ssj0001476705
ssib044733217
Score 2.2880676
Snippet Gastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate immune pathogenic...
Background & AimsGastric cancer (GC) is strongly linked with chronic gastritis after Helicobacter pylori infection. Toll-like receptors (TLRs) are key innate...
SourceID pubmedcentral
proquest
pubmed
crossref
nii
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 567
SubjectTerms Animals
Carcinogenesis
Carcinogenesis - pathology
Cell Proliferation
Cytokine Receptor gp130
Cytokine Receptor gp130 - metabolism
Gastric Cancer
Gastric Mucosa
Gastric Mucosa - pathology
Gastritis
Gastritis - pathology
Gastroenterology and Hepatology
H pylori
Helicobacter Infections
Helicobacter Infections - metabolism
Helicobacter pylori
Helicobacter pylori - metabolism
Humans
Hyperplasia
Hyperplasia - pathology
Inflammation
Inflammation - pathology
Initiation
Ligands
Mice
NF-kappa B
NF-kappa B - metabolism
Original Research
Stomach Neoplasms
Stomach Neoplasms - pathology
TLR9
Toll-Like Receptor 9
Toll-Like Receptor 9 - genetics
Toll-Like Receptor 9 - metabolism
Title Toll-like Receptor 9 Promotes Initiation of Gastric Tumorigenesis by Augmenting Inflammation and Cellular Proliferation
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2352345X22001011
https://www.clinicalkey.es/playcontent/1-s2.0-S2352345X22001011
https://dx.doi.org/10.1016/j.jcmgh.2022.06.002
https://cir.nii.ac.jp/crid/1871146592895102848
https://www.ncbi.nlm.nih.gov/pubmed/35716851
https://www.proquest.com/docview/2678430139
https://pubmed.ncbi.nlm.nih.gov/PMC9307956
Volume 14
WOSCitedRecordID wos000860358300004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2352-345X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001476705
  issn: 2352-345X
  databaseCode: DOA
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2352-345X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssib044733217
  issn: 2352-345X
  databaseCode: M~E
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbWgRAviDsFNhmJtxHUuE5sP1bVAGkXTaIPfbMc1-lS2nRq2jFe-F38PI6dOGnpNi4SL1aV2knq8_Vc7OPvIPQ2EkqP4lAFIe-kATUQsApN04CDM2tSMHhGORLXY3Z6yodDcbaz88OfhbmcsjznV1fi4r-KGq6BsO3R2b8Qd31TuACfQejQgtih_TPBg2SDafbFFmSwOSvzxYGw5wFAJqYAfZAts9pN_Khs2Q59MFjNbIUsq_eywnqkvdXY5RG5dIIUUFOecHRbDX0znbrk1TNb8Sc1i0a4nvLA97DdZ74A78HYPm1uSUAXDfPTOdjD5cba_qBawj5q0nLr_OTj-SprtpOOs4oiYXAOdi5rLIwpT7L0pq7AYn99aYOQtaUNpwEJeIdBl0bD0lhtX9vS_-VSxOT9RM_GdquJEMfO2iGNufNb_If9ozAo4Pvgs72nvSUhjnIv3OxcxkqyILIjt7q20B3CIsHXgnm3ukdZzFz-bP2-nvLKJRduvd9NblErz7Lrgp9fc3jXnKLBQ_SgimZwr0ThI7Rj8sfo3kmVr_EEfa3BiD0YscAejLgBI56nuAIj3gAjTr7hBox4HYwY4IM91PAGGJ-iwYfDQf9TUJX6CDQ4iMsgpDpOOkrHlBmhFBtRsDQCNAWjlKmEpynhmhIWg0cbs0SHahRqFfKRGBEl0u4ztJvPc_MCYZFyRmJjupQaCmpHKJ4kirBOmnR1NKJtRPxES13R4NtqLFPp8x0n0klHWulIl_VJ2uhdPeiiZIG5vTv1EpT-gDOYZAkovX0Yu26YKSrtUsibUNhGcT2y8pxLj_j3j9wDgMFE2DbkzHIURIJwG3eB48rb6I2HngS7YzcTVW7mq0IS8HJp1waQbfS8hGI9Nd2IhTGEcvCDNkBad7Cc9pvf5Nm547YX4HOIKH75z1PxCt1vVMlrtLtcrMweuqsvl1mx2EctNuT77r8K7cn3w592Wx0u
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Toll-like+Receptor+9+Promotes+Initiation+of+Gastric+Tumorigenesis+by+Augmenting+Inflammation+and+Cellular+Proliferation&rft.jtitle=Cellular+and+molecular+gastroenterology+and+hepatology&rft.au=Tang%2C+Ke&rft.au=McLeod%2C+Louise&rft.au=Livis%2C+Thaleia&rft.au=West%2C+Alison+C&rft.date=2022-01-01&rft.issn=2352-345X&rft.eissn=2352-345X&rft_id=info:doi/10.1016%2Fj.jcmgh.2022.06.002&rft.externalDBID=ECK1-s2.0-S2352345X22001011&rft.externalDocID=1_s2_0_S2352345X22001011
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-345X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-345X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-345X&client=summon